Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gomes Dos Santos, Ana L."'
Autor:
Ouberai, Myriam M., Gomes Dos Santos, Ana L., Kinna, Sonja, Hornigold, David C., Baker, David, Naylor, Jacqueline, Liang, Lihuan, Corkill, Dominic J., Welland, Mark E.
Publikováno v:
Frontiers in Endocrinology; 2023, p1-14, 14p
Autor:
Gomes dos Santos, Ana L., Bochot, Amélie, Doyle, Aoife, Tsapis, Nicolas, Siepmann, Juergen, Siepmann, Florence, Schmaler, Jeannette, Besnard, Madeleine, Behar-Cohen, Francine, Fattal, Elias
Publikováno v:
In Journal of Controlled Release 2006 112(3):369-381
Autor:
Ambrosio, Elena, Podmore, Adrian, Gomes dos Santos, Ana L., Magarkar, Aniket, Bunker, Alex, Caliceti, Paolo, Mastrotto, Francesca, van der Walle, Christopher F., Salmaso, Stefano
Publikováno v:
Biomacromolecules; Oct2018, Vol. 19 Issue 10, p3958-3969, 12p
Autor:
Ouberai, Myriam M., Gomes Dos Santos, Ana L., Kinna, Sonja, Madalli, Shimona, Hornigold, David C., Baker, David, Naylor, Jacqueline, Sheldrake, Laura, Corkill, Dominic J., Hood, John, Vicini, Paolo, Uddin, Shahid, Bishop, Steven, Varley, Paul G., Welland, Mark E.
Publikováno v:
Nature Communications; 10/18/2017, Vol. 8 Issue 1, p1-9, 9p
Publikováno v:
Pharmaceutics; Nov2021, Vol. 13 Issue 11, p1837, 1p
Autor:
Kinna, Sonja1 (AUTHOR), Ouberaï, Myriam M.1 (AUTHOR) mew10@cam.ac.uk, Sonzini, Silvia2 (AUTHOR), Gomes Dos Santos, Ana L.1,2 (AUTHOR) ana.gomesdossantos@astrazeneca.com, Welland, Mark E.1,2 (AUTHOR)
Publikováno v:
International Journal of Pharmaceutics. Jul2021, Vol. 604, pN.PAG-N.PAG. 1p.
Autor:
Oeller M; Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany., Kang RJD; Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Bolt HL; Hit Discovery, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gomes Dos Santos AL; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Weinmann AL; Early Chemical Development, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Nikitidis A; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Zlatoidsky P; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Su W; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Czechtizky W; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., De Maria L; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Sormanni P; Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. ps589@cam.ac.uk., Vendruscolo M; Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. mv245@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 17; Vol. 14 (1), pp. 7475. Date of Electronic Publication: 2023 Nov 17.
Autor:
Gomes dos Santos AL; INSERM U 598, 15 rue de l'Ecole de Médecine, 75270, Paris, Cedex 06, France., Bochot A, Tsapis N, Artzner F, Bejjani RA, Thillaye-Goldenberg B, de Kozak Y, Fattal E, Behar-Cohen F
Publikováno v:
Pharmaceutical research [Pharm Res] 2006 Apr; Vol. 23 (4), pp. 770-81. Date of Electronic Publication: 2006 Apr 06.